Therapy-Related Malignant Neoplasm — Trials

Therapy-Related Malignant Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

94 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 28
Recruiting: 13
Ph III recruiting: 1
Growth YoY: —
Industry share: 7%
Top sponsor: National Cancer Institute (NCI)
Termination share: 26.1%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (12)

clinicaltrialsPublishedShowing 1–1 of 1 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT01751243	Transplantation of Hematopoietic Progenitors From Haploidentical Donor With Selective in Vitro Depletion Allo-reactive Lymphocytes in Patient With High Risk Hematological Malignancies	withdrawn	Phase 1	0	Andalusian Initiative for Advanced Therapies - Fundación Pública Andaluza Progreso y SaludOTHER	1	Jul 6, 2018	clinicaltrials

Data updated 22 days agoSource updated Jul 6, 2018source: clinicaltrials